Solasia Pharma K.K.
ソレイジア・ファーマ株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4597
FY2025 · 2025-12-31
| Gross margin | 48.3% |
| Operating margin | -200.7% |
| Net margin | -204.2% |
| Return on equity | -50.0% |
| Return on assets | -40.8% |
| Revenue growth (YoY) | 35.8% |
| EPS (basic) | ¥-3.69 |
| EPS growth (YoY) | — |
| Current ratio | — |
| Equity ratio | — |
| Book value / share | ¥6.15 |
| Free cash flow | -847 M |